Menu

• Ask a Health Expert about CEREBRAL ARTERY OCCLUSION
• Post Your Side Effect related to CEREBRAL ARTERY OCCLUSION
• CEREBRAL ARTERY OCCLUSION and FDA Warnings
• CEREBRAL ARTERY OCCLUSION in Patients Wiki
• Report CEREBRAL ARTERY OCCLUSION in Drug Side Effect Survey

CEREBRAL ARTERY OCCLUSION side effect

What is CEREBRAL ARTERY OCCLUSION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Remicade Side Effects Report #5675651-7
Consumer or non-health professional from UNITED STATES reported REMICADE problem on Mar 11, 2008. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis, arterial occlusive disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, transient ischaemic attack, . REMICADE dosage: unknown. During the same period patient was treated with CELEBREX, COUMADIN, PLAQUENIL, PREDNISONE, FOSAMAX. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5623838-1
CLOFARABINE problem was reported by a Physician from CANADA on Feb 01, 2008. Female patient, child 9 years of age, was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebrovascular accident, dehydration, diarrhoea, radiation injury, skin hypertrophy, vasculitis, . CLOFARABINE dosage: 52 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Miacalcin Side Effects Report #5591232-8
Physician from TURKEY reported MIACALCIN problem on Jan 08, 2008. Female patient was treated with MIACALCIN. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, . MIACALCIN dosage: unknown. Patient recovered.

Tykerb Side Effects Report #5598345-5
TYKERB problem was reported by a Physician from GERMANY on Jan 17, 2008. Female patient, 54 years of age, weighting 138.9 lb, was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, hemiparesis, speech disorder, thrombocythaemia, . TYKERB dosage: unknown. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.


Miacalcin Side Effects Report #5569373-0
Physician from TURKEY reported MIACALCIN problem on Dec 13, 2007. Female patient was treated with MIACALCIN. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, . MIACALCIN dosage: unknown. Patient recovered.

Celebrex Side Effects Report #5730877-9
CELEBREX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 29, 2008. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, transient ischaemic attack, . CELEBREX dosage: unknown. During the same period patient was treated with REMICADE, COUMADIN, PLAQUENIL, PREDNISONE, FOSAMAX. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5713068-7
Physician from JAPAN reported CAPECITABINE problem on Apr 14, 2008. Male patient, weighting 131.6 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebral artery stenosis, cerebral infarction, haemoglobin decreased, mallory-weiss syndrome, upper gastrointestinal haemorrhage, . CAPECITABINE dosage: unknown. During the same period patient was treated with CISPLATIN, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, SUCRALFATE, ALUMINUM HYDROXIDE, ALUMINUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Celebrex Side Effects Report #5344460-0
CELEBREX problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Male patient, weighting 140.0 lb, was diagnosed with back pain and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebral infarction, . CELEBREX dosage: unknown. During the same period patient was treated with BEXTRA. Patient recovered.

Celebrex Side Effects Report #5354750-3
Consumer or non-health professional from UNITED STATES reported CELEBREX problem on May 31, 2007. Male patient, weighting 255.1 lb, was diagnosed with back pain and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, ischaemic stroke, . CELEBREX dosage: unknown. During the same period patient was treated with BEXTRA. Patient was hospitalized. Patient recovered.


Seroquel Side Effects Report #5275683-7
SEROQUEL problem was reported by a Pharmacist from UNITED STATES on Apr 05, 2004. Male patient, 49 years of age, was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, . SEROQUEL dosage: 200 MG IN MORNING, 400 MG IN EVENING. During the same period patient was treated with NEXIUM. Patient recovered.

Oncaspar Side Effects Report #5664088-2
Physician from UNITED STATES reported ONCASPAR problem on Feb 28, 2008. Female patient, weighting 31.31 lb, was diagnosed with acute lymphocytic leukaemia and was treated with ONCASPAR. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral artery occlusion, cerebral ischaemia, cerebrovascular accident, protein s decreased, . ONCASPAR dosage: unknown. During the same period patient was treated with CEFTAZIDIME, PREDNISONE, PEPCID, DIFLUCAN, BACTRIM. Patient was hospitalized. Patient recovered.

Emsam Side Effects Report #5463809-1
EMSAM problem was reported by a Physician from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, hemianopia homonymous, . EMSAM dosage: 6 MILLIGRAM, 24 HOUR TD. During the same period patient was treated with AMBIEN CR, ADALAT, ASPIRIN, DARVOCET, DEPAKOTE, FOLIC ACID, FOSAMAX, INSULIN. Patient recovered.

Zelnorm Side Effects Report #5405956-6
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on June 19, 2007. Male patient, 51 years of age, was diagnosed with constipation, hyperlipidaemia, hypertension and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral artery occlusion, cerebral infarction, cerebrovascular accident, fatigue, memory impairment, nervousness, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with PLAVIX, ZOCOR, LISINOPRIL, FOLIC ACID, ASPIRIN. Patient was hospitalized. Patient recovered.

Cilostazol Side Effects Report #5391805-1
CILOSTAZOL problem was reported by a Physician from KOREA, REPUBLIC OF on July 03, 2007. Female patient, 79 years of age, was diagnosed with cerebrovascular accident, prophylaxis and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cerebral artery occlusion, cerebral infarction, depressed level of consciousness, disease recurrence, pulmonary embolism, . CILOSTAZOL dosage: ONE OF 200 MG; ORAL. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.


Cilostazol Side Effects Report #5391805-1
Physician from KOREA, REPUBLIC OF reported CILOSTAZOL problem on July 03, 2007. Female patient, 79 years of age, was diagnosed with cerebrovascular accident, prophylaxis and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cerebral artery occlusion, cerebral infarction, depressed level of consciousness, disease recurrence, pulmonary embolism, . CILOSTAZOL dosage: ONE OF 200 MG; ORAL. During the same period patient was treated with CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Crestor Side Effects Report #5727584-5
CRESTOR problem was reported by a Physician from UNITED STATES on Apr 28, 2008. Female patient, 47 years of age, weighting 231.9 lb, was diagnosed with blood cholesterol and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cerebral artery occlusion, dyspnoea, gait disturbance, headache, heart rate irregular, muscular weakness, myalgia, nausea, . CRESTOR dosage: unknown. During the same period patient was treated with METFORMIN, ZOLOFT, LORCET. Patient was hospitalized. Patient recovered.

Ortho Side Effects Report #5333266-4
Consumer or non-health professional from UNITED STATES reported ORTHO EVRA problem on May 15, 2007. Female patient, 23 years of age, was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebrovascular accident, . ORTHO EVRA dosage: unknown. Patient died on 02/05/2006.

Alteplase Side Effects Report #5266728-9
ALTEPLASE problem was reported by a Physician from GERMANY on Mar 01, 2007. Female patient, 26 years of age, was diagnosed with cerebral artery occlusion and was treated with ALTEPLASE. After drug was administered, patient experienced the following problems/side effects: antiphospholipid syndrome, cerebral artery occlusion, ischaemic cerebral infarction, premature labour, . ALTEPLASE dosage: 0.9 MG/KG, SINGLE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5657646-2
Physician from CANADA reported CLOFARABINE problem on Feb 27, 2008. Female patient, child 9 years of age, was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, asthenia, cerebral artery occlusion, cerebrovascular accident, dehydration, diarrhoea, pulmonary oedema, radiation injury, skin hypertrophy, . CLOFARABINE dosage: 52 MG/M2, INTRAVENOUS; 40 MG/M2, QDX5, INTRAVENOUS. Patient was hospitalized. Patient died on 02/25/2008.


Enbrel Side Effects Report #5579112-5
ENBREL problem was reported by a Physician from UNITED STATES on Dec 19, 2007. Female patient, weighting 141.1 lb, was diagnosed with juvenile arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: anaemia, cataract, cerebral artery occlusion, cerumen impaction, constipation, deafness neurosensory, dental caries, glaucoma surgery, haematochezia, . ENBREL dosage: unknown. During the same period patient was treated with TOLECTIN, VIOXX, PREDNISONE, ZANTAC, ARAVA, METHOTREXATE, NYSTATIN, CENTRUM. Patient was hospitalized. Patient recovered.

Methotrexate Side Effects Report #5385937-1
Consumer or non-health professional from AUSTRALIA reported METHOTREXATE problem on June 26, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, brain abscess, cerebral artery occlusion, cerebral infarction, encephalitis, erythema of eyelid, exophthalmos, eye pain, eyelid ptosis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISONE, ADALIMUMAB. Patient was hospitalized. Patient died.

Methotrexate Side Effects Report #5385937-1
METHOTREXATE problem was reported by a Consumer or non-health professional from AUSTRALIA on June 26, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, brain abscess, cerebral artery occlusion, cerebral infarction, encephalitis, erythema of eyelid, exophthalmos, eye pain, eyelid ptosis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISONE, ADALIMUMAB. Patient was hospitalized. Patient died.

Renivace Side Effects Report #5758965-1
Physician from JAPAN reported RENIVACE problem on May 14, 2008. Female patient, 75 years of age, was diagnosed with hypertension, embolic stroke and was treated with RENIVACE. After drug was administered, patient experienced the following problems/side effects: angioedema, atrial fibrillation, cerebral artery occlusion, embolic stroke, fall, unresponsive to stimuli, . RENIVACE dosage: 2.5 MG QD; ORAL. During the same period patient was treated with ACTIVASE, TRICHLORMETHIAZIDE, ASPIRIN. Patient was hospitalized. Patient recovered.

Reclast Side Effects Report #5772300-4
RECLAST problem was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2008. Female patient, weighting 125.0 lb, was diagnosed with osteopenia, headache and was treated with RECLAST. After drug was administered, patient experienced the following problems/side effects: acute phase reaction, blood pressure decreased, cerebral artery occlusion, cerebral artery thrombosis, cerebrovascular accident, constipation, fatigue, headache, hemiparesis, . RECLAST dosage: 5 MG, ONCE/SINGLE. During the same period patient was treated with VITAMIN E, CALCIUM WITH VITAMIN D, MAGNESIUM, VITAMINS PLUS IRON, BENICAR, PROTONIX, AMITIZA, FIORINAL. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5699148-3
Consumer or non-health professional from UNITED STATES reported HEPARIN problem on Apr 09, 2008. Female patient, 80 years of age, weighting 110.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abasia, blood pressure decreased, cerebral artery occlusion, cerebrovascular accident, depressed level of consciousness, heart rate decreased, incision site haemorrhage, . HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Grtpa Side Effects Report #5268377-5
GRTPA problem was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Male patient, 87 years of age, was diagnosed with cerebral artery embolism, atrial fibrillation and was treated with GRTPA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood alkaline phosphatase increased, cerebral artery occlusion, cerebral thrombosis, haemorrhagic cerebral infarction, multi-organ failure, platelet count decreased, renal impairment, respiratory disorder, . GRTPA dosage: 2.9 ML, INTRAVENOUS, 26.1 ML, IV DRIP. During the same period patient was treated with HEPARIN, RADICUT, FAMOTIDINE, GLYCERIN. Patient died on 12/02/2006.